Active, not recruitingNCT05057637

The Impact of Optical Coherence Tomography on the Endovascular Treatment Planning of Femoropopliteal Disease

Studying PLA2G6-associated neurodegeneration

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rijnstate Hospital
Principal Investigator
Michel Reijnen, MD, prof
Rijnstate Hospital
Intervention
Optical coherence tomography measurements(device)
Enrollment
25 target
Eligibility
18 years · All sexes
Timeline
20222027

Study locations (1)

Collaborators

University of Twente · Abbott

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05057637 on ClinicalTrials.gov

Other trials for PLA2G6-associated neurodegeneration

Additional recruiting or active studies for the same condition.

See all trials for PLA2G6-associated neurodegeneration

← Back to all trials